Cell Counting Market Size of Key Players, Share Analysis, Price and Revenue Forecast 2024-2032
The latest report by IMARC Group, titled “Cell Counting Market Report by Product Type (Consumables, Instruments), End User (Hospitals and Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Region 2024-2032“, The global cell counting market size reached US$ 12.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.18% during 2024-2032.
Cell counting is a vital technique used to analyze cells or micelles found in blood or other bodily fluids. It is essential in maintaining cell cultures and preparing cells for various biological procedures and downstream experiments. It involves the utilization of advanced devices that employ diverse quantification principles, including flow cytometers, spectrometers, cell counters, microplates, and other cutting-edge technologies. It enables researchers to accurately assess cell populations and ensure optimal conditions for subsequent scientific investigations. It aids in cell classification, disease detection, and the development of optimal treatment plans for patients. It also plays a crucial role in the field of life sciences, wherein several accurate cell counting methods are used, including hemocytometers (counting chambers), electrical resistance, and automated cell counting (electronic cell counting). It provides useful insights into the structure and composition of cells, enabling chromosome analysis, protein expression studies, cancer diagnosis, and hematological malignancy investigations. As a result, cell counting finds extensive applications in hospitals, diagnostic laboratories, research, academic institutions, and the pharmaceutical and biotechnology sectors across the globe.Cell Counting Market Trends and Drivers:
The global cell
counting market is primarily driven by the rising prevalence of numerous chronic
diseases such as cancer, HIV-AIDS, leukemia, and Alzheimer's disease. Moreover,
the surging adoption of cell counting instruments across diverse medical
fields, including molecular biology, immunology, and pathology, as they
contribute to the development of next-generation therapeutics, is positively
influencing the market growth. Apart from this, the increasing utilization of
cell counting for identifying and assessing primary tumors, circulating tumors,
and metastatic tumors has catalyzed market growth. Additionally, the growing
adoption of stem cell therapy has augmented the demand for cell counting
instruments. Besides this, the rising awareness about the benefits of cell
counting techniques in immunophenotyping, cell sorting, cell proliferation assays,
and intracellular calcium flux is propelling market growth. Furthermore,
governments of numerous countries are investing in extensive research and
development (R&D) activities in the fields of biotechnology, oncology, and
stem cell therapeutics, which in turn has accelerated the product adoption
rate. Along with this, the introduction of automated product variants capable
of processing larger sample sizes at higher speeds and the widespread
availability of high-throughput flow cytometry and automated instruments that
improve the reliability of products is another major growth-inducing factor.
Other factors, including the rising importance of cell counting in patients
suffering from coronavirus disease (COVID-19), an increasing number of cellular
research initiatives, technological advancements, and rapid growth of the
biotechnology and biopharmaceutical industries, are also anticipated to drive
the market further.
For an in-depth analysis, you can refer sample
copy of the report: https://www.imarcgroup.com/cell-counting-market/requestsample
Report Segmentation:
The report has segmented the market into the
following categories:
Breakup by Product Type:
- Consumables
- Reagents
- Assay Kits
- Microplates
- Accessories
- Instruments
- Spectrophotometers
- Flow Cytometers
- Hematology Analyzers
- Cell Counters
Breakup by End User:
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia,
Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Agilent Technologies Inc.
- Becton
- Dickinson and Company
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd. (Roche Holding AG).
- Merck & Co. Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Note: If you need specific information that is
not currently within the scope of the report, we will provide it to you as a
part of the customization.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
Comments
Post a Comment